Skip to content
10-Q

Quarterly Report

HeartSciences Inc. HSCS HSCSW

0001468492-25-000010

← back to feed
Filed
Sep 11, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Sep 10, 2025 2.65M sh
Shares Diluted Q1 2025 · Jul 31, 2025 1.3M sh
Shares Diluted Q1 2025 · Jul 31, 2024 777.75K sh
Operating Cash Flow Q1 2025 · Jul 31, 2025 −$1.95M
Operating Cash Flow Q1 2025 · Jul 31, 2024 −$2.02M
Cash And Equivalents Q1 2025 · Jul 31, 2025 $2.79M
Cash And Equivalents Q1 2025 · Apr 30, 2025 $1.1M
Stockholders Equity Q1 2025 · Jul 31, 2025 $3.14M
Stockholders Equity Q1 2025 · Apr 30, 2025 $205.17K
Stockholders Equity restated Q1 2025 · Jul 31, 2024 $5.93M
Stockholders Equity restated Q1 2025 · Apr 30, 2024 $7.32M
Current Liabilities Q1 2025 · Jul 31, 2025 $3.01M
Current Liabilities Q1 2025 · Apr 30, 2025 $3.7M
Total Liabilities Q1 2025 · Jul 31, 2025 $3.3M
Total Liabilities Q1 2025 · Apr 30, 2025 $4.02M
Current Assets Q1 2025 · Jul 31, 2025 $4.42M
Current Assets Q1 2025 · Apr 30, 2025 $2.17M
Total Assets Q1 2025 · Jul 31, 2025 $6.44M
Total Assets Q1 2025 · Apr 30, 2025 $4.22M
Eps Diluted Q1 2025 · Jul 31, 2025 −$1.58
Eps Diluted Q1 2025 · Jul 31, 2024 −$2.64
Eps Basic Q1 2025 · Jul 31, 2025 −$1.58
Eps Basic Q1 2025 · Jul 31, 2024 −$2.64
Sga Expense Q1 2025 · Jul 31, 2025 $878.05K
Sga Expense Q1 2025 · Jul 31, 2024 $850.74K
Rd Expense Q1 2025 · Jul 31, 2025 $997.21K
Rd Expense Q1 2025 · Jul 31, 2024 $1.22M
Net Income Q1 2025 · Jul 31, 2025 −$2.05M
Net Income Q1 2025 · Jul 31, 2024 −$2.05M
Operating Income Q1 2025 · Jul 31, 2025 −$1.87M
Operating Income Q1 2025 · Jul 31, 2024 −$2.08M
Gross Profit Q1 2025 · Jul 31, 2025 $1.14K
Cost Of Revenue Q1 2025 · Jul 31, 2025 $760
Revenue Q1 2025 · Jul 31, 2025 $1.9K